obesity-995x60.png
FEATURED ARTICLES
Participant Payment — Make It Make Cents
Participant payment practices and expectations vary wildly. With advocate T.J. Sharpe, explore why sponsors need to rethink how they appreciate participants' time, effort, and burden.
-
![arena of spectators-GettyImages-1500529551]( "What Ecological Momentary Assessment Taught Us About Real-World Hearing Outcomes")
What Ecological Momentary Assessment Taught Us About Real-World Hearing OutcomesEcological momentary assessment (EMA) reveals how people experience hearing challenges beyond the clinic. Here, researchers highlight its relevance in designing real-world hearing studies.
-
![clinical-trial-study-design-GettyImages-2215843204]( "Harness An Adept IRB's Expertise To Streamline Study Design")
Harness An Adept IRB's Expertise To Streamline Study DesignAn Institutional Review Board protects human research participants by evaluating study ethics, consent, and risks, while providing sponsors with ongoing guidance on complex trial protocols.
-
![Oncolytic Virus immunology, immunotherapy, cancer vaccine-GettyImages-1445620397]( "Calidi's Study Aims To Have An Oncolytic Virus Outsmart The Immune System")
Calidi's Study Aims To Have An Oncolytic Virus Outsmart The Immune SystemCalidi’s Eric Poma, Ph.D., explains how CLD-401 could evade immune clearance — and how the biotech is designing Phase 1 to prove safety and efficacy fast.
SERVICES AND PRODUCTS
Explore the breadth of Altasciences’ expertise in clinical pharmacology studies, supporting regulatory submissions across a diverse range of therapeutic areas.
Managing clinical trial disclosure can be challenging with the ever-evolving regulatory landscape, and varying requirements across different jurisdictions and regulatory bodies. New and updated regulations need to be continuously monitored and assessed for potential impact on an organization, processes and overall strategy.
Ypsomed accelerates clinical progress by reducing barriers across clinical development, enabling earlier study readiness, greater visibility and more informed decisions.
Explore validated pain models and integrated early-phase services designed to characterize dose response, evaluate safety and efficacy, and support informed decisions in analgesic development.
DECODE, the Digital Endpoint Collaboration for Outcomes Development, is Ametris’ pre-competitive collaboration framework designed to help address shared clinical measurement challenges across the life sciences industry. In regulatory contexts where evidence expectations are high, digital measures must be meaningful to patients, scientifically valid, operationally feasible, and aligned with regulatory expectations. By supporting the development and validation of fit-for-purpose, patient-centered digital measures, DECODE helps transform real-world data into validated clinical evidence across clinical research programs.